Skybound Medtech
Houston, US · Founded 2025 · Texas corporation
Skybound develops platform medical technologies targeting the physiological barriers to long-duration human spaceflight—such as bone loss, muscle atrophy, immune dysregulation, and radiation-induced damage—and applies the same technologies to major terrestrial health problems. Its focus areas include delaying and reversing age-related decline and chronic disease, delivering remote healthcare with minimal clinician supervision, and personalized real-time therapies.
Founders & leadership
MK
Matthew KuhnExecutive
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2026
▶$1.3MraisedJul 2026 · 5 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJul 2026 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
- Matthew KuhnExecutive Officer
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jun 2026
- Incorporated
- Corporation, Texas, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Skybound Medtech do?
- Skybound develops platform medical technologies targeting the physiological barriers to long-duration human spaceflight—such as bone loss, muscle atrophy, immune dysregulation, and radiation-induced damage—and applies the same technologies to major terrestrial health problems. Its focus areas include delaying and reversing age-related decline and chronic disease, delivering remote healthcare with minimal clinician supervision, and personalized real-time therapies.
- How much funding has Skybound Medtech raised?
- Skybound Medtech has disclosed $1.3M raised across 1 round.
- Where is Skybound Medtech headquartered?
- Skybound Medtech is headquartered in Houston, US.